Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

PSCI 169C > Week 2 > Flashcards

Week 2 Flashcards

1
Q

Childhood Videotaped Social and Neuromotor Precursors of Schizophrenia

Study Objective

A

To examine social and neuromotor behaviors in children who later developed schizophrenia compared to those who did not.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Childhood Videotaped Social and Neuromotor Precursors of Schizophrenia

Study Design

A

Longitudinal study using childhood videotapes of Danish children aged 11–13 in 1972, with adult diagnostic follow-up in 1991.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Childhood Videotaped Social and Neuromotor Precursors of Schizophrenia

Key Findings

A
  1. Preschizophrenia children showed reduced sociability and, in boys, neuromotor deficits.
  2. Differences were specific to schizophrenia, not other psychiatric disorders.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Childhood Videotaped Social and Neuromotor Precursors of Schizophrenia

Neuromotor Deficits

A

Poor motor coordination and increased involuntary movements observed in childhood predicted schizophrenia in adulthood.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Childhood Videotaped Social and Neuromotor Precursors of Schizophrenia

Conclusions

A

Findings support a neurodevelopmental hypothesis of schizophrenia, with social and motor deficits as early precursors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Childhood Precursors of Schizophrenia

Neuromotor Abnormalities

A

Children who later developed schizophrenia displayed higher rates of neurological “soft signs” like involuntary movements, poor coordination, and dyskinesia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Childhood Precursors of Schizophrenia

Social Behavior Deficits

A

Children who developed schizophrenia showed reduced sociability, fewer smiles, and less vocal interaction compared to peers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Childhood Precursors of Schizophrenia

High-Risk Sample

A

Children with a parent diagnosed with schizophrenia had increased likelihood of developing schizophrenia-related disorders.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Childhood Precursors of Schizophrenia

Gender Differences

A

Boys showed more pronounced neuromotor deficits, while social impairments were observed across genders.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Childhood Precursors of Schizophrenia

Videotape Coding Variables

A

Included measures of smiles, laughter, involuntary hand movements, nystagmus-like eye movements, and abnormal motor signs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Childhood Precursors of Schizophrenia

Strengths of the Study

A
  1. Prospective design with standardized videotaping protocols.
  2. Long-term follow-up (20 years).
  3. Use of DSM-III-R criteria for adult psychiatric diagnoses.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Childhood Precursors of Schizophrenia

Study Limitations

A
  1. Small sample size for schizophrenia group (N=16).
  2. Moderate interrater reliability for neuromotor measures.
  3. Missing videotape data for some subjects.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Childhood Precursors of Schizophrenia

Longitudinal Results

A

Differences in childhood behaviors were consistent with adult diagnostic outcomes, supporting a neurodevelopmental hypothesis of schizophrenia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Epidemiology of Schizophrenia: Global Insights

Global Prevalence

A

Schizophrenia affects 1.4–4.6 per 1000 individuals globally, with small variations across populations.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Epidemiology of Schizophrenia: Global Insights

Incidence Rates

A

Schizophrenia incidence is 0.16–0.42 per 1000 annually, with minimal global variation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Epidemiology of Schizophrenia: Global Insights

Better Outcomes in Developing Countries

A

Patients in developing nations have higher remission rates and lower social impairment, often without sustained medication.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Epidemiology of Schizophrenia: Global Insights

Key Risk Factors

A

Genetic predisposition, early neurodevelopmental issues, and environmental interactions are primary contributors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Epidemiology of Schizophrenia: Global Insights

Sex Differences

A

Earlier onset in men; women show better premorbid functioning, outcomes, and fewer brain abnormalities.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Epidemiology of Schizophrenia: Global Insights

Schizophrenia Prevalence

A

Occurs in 1.4–4.6 per 1000 people globally, with a consistent prevalence across most populations but notable exceptions, such as isolated or endogamous communities.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Epidemiology of Schizophrenia: Global Insights

Incidence Rates

A

Annual incidence ranges from 0.16 to 0.42 per 1000 individuals, with “broad” criteria (ICD-9) showing higher rates than restrictive diagnostic criteria (DSM or ICD-10).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Epidemiology of Schizophrenia: Global Insights

Better Outcomes in Developing Countries

A

Schizophrenia patients in developing nations (India, Nigeria, Colombia) experience higher remission rates, better social integration, and less chronic disability compared to those in developed countries.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Epidemiology of Schizophrenia: Global Insights

Potential Factors for Better Outcomes in Developing Countries

A

Differences may involve acute illness onset, supportive social networks, and reduced stigma, though environmental and genetic interactions are not fully understood.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Epidemiology of Schizophrenia: Global Insights

WHO Ten-Country Study Findings

A
  1. Remission rates were higher in developing countries (62.7%) compared to developed countries (36.8%).
  2. Fewer patients in developing countries required long-term hospitalization or antipsychotic medication.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Epidemiology of Schizophrenia: Global Insights

Sex Differences in Schizophrenia

A

Men: Earlier onset (by 4–5 years), worse premorbid functioning, and more brain abnormalities.

Women: Better outcomes and higher remission rates, especially post-menopause.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
**Epidemiology of Schizophrenia: Global Insights** Challenges in Diagnosing Schizophrenia in Epidemiology
1. Reliance on self-reports and lack of biological markers complicates diagnosis. 2. Verbatim diagnostic interviews (e.g., DIS, CIDI) have limited sensitivity for psychosis.
26
**Epidemiology of Schizophrenia: Global Insights** Impact of Late-Onset Schizophrenia
Schizophrenia onset after 40 years changes sex ratios (more common in women) and symptoms, with predominance of delusions and fewer negative symptoms.
27
**Epidemiology of Schizophrenia: Global Insights** Historical Development of Schizophrenia Epidemiology
1. Early studies by Kraepelin focused on heredity and cultural factors. 2. Modern epidemiology uses longitudinal and cross-cultural methods to understand schizophrenia's global distribution.
28
**Epidemiology of Schizophrenia: Global Insights** Population-Specific Observations
1. Low prevalence in Hutterite communities due to genetic selection and cultural norms. 2. High prevalence in isolated populations like northern Sweden and Croatia due to genetic bottlenecks.
29
**Epidemiology of Schizophrenia: Global Insights** Course and Prognosis of Schizophrenia
1. Chronic but highly variable course; up to 60% achieve remission after long-term follow-up. 2. Longitudinal studies confirm higher recovery rates in developing nations.
30
**Categorical versus dimensional models of early psychosis** Categorical Model of Psychosis
Psychosis is viewed as a distinct, separate entity from normal mental functioning, classified into discrete disorders like schizophrenia or bipolar disorder.
31
**Categorical versus dimensional models of early psychosis** Dimensional Model of Psychosis
Psychotic symptoms are seen on a continuum, varying in severity across the general population rather than being confined to specific diagnoses.
32
**Categorical versus dimensional models of early psychosis** Key Differences Between Models
- Categorical Model: Clear boundaries between "ill" and "healthy." - Dimensional Model: Overlapping symptoms and gradients of severity across populations.
33
**Categorical versus dimensional models of early psychosis** Advantages of the Dimensional Model
1. Reflects the full spectrum of psychotic experiences. 2. Captures subthreshold symptoms and early markers. 3. Allows for personalized treatment approaches.
34
**Categorical versus dimensional models of early psychosis** Limitations of the Dimensional Model
1. Challenges traditional diagnostic boundaries. 2. Difficult to apply in legal and clinical contexts requiring categorical decisions.
35
**Categorical versus dimensional models of early psychosis** Clinical Utility of Categorical Models
- Clear criteria aid in diagnosis and treatment decisions. - Useful for research standardization and epidemiological studies.
36
**Categorical versus dimensional models of early psychosis** Continuum of Psychotic Experiences
Psychotic symptoms, such as hallucinations or delusions, occur in milder forms in the general population, with only severe cases meeting clinical thresholds.
37
**Categorical versus dimensional models of early psychosis** Subthreshold Symptoms
Symptoms that do not meet full diagnostic criteria but indicate vulnerability to developing psychotic disorders.
38
**Categorical versus dimensional models of early psychosis** Implications for Early Intervention
Dimensional models support identifying and treating individuals with mild or subclinical symptoms to prevent full-blown psychosis.
39
**Categorical versus dimensional models of early psychosis** Neurobiological Correlates
Evidence supports shared genetic and neurobiological underpinnings across psychotic disorders, aligning with the dimensional model.
40
**Categorical versus dimensional models of early psychosis** Hybrid Approaches
Combines categorical and dimensional perspectives to capture the complexity of psychosis and improve diagnostic accuracy.
41
**Categorical versus dimensional models of early psychosis** Criticisms of Categorical Models
1. Oversimplifies complex symptom presentations. 2. May overlook individuals with significant impairment but no diagnosis.
42
**Categorical versus dimensional models of early psychosis** Transdiagnostic Research
Studies focusing on shared mechanisms across disorders, supporting the dimensional approach.
43
**Categorical versus dimensional models of early psychosis** Global Burden of Psychosis
Psychotic disorders are significant contributors to disability worldwide, highlighting the need for comprehensive diagnostic models.
44
**Schizophrenia Spectrum Disorders** Schizophrenia Spectrum Disorders
A group of related conditions sharing psychotic features, including schizophrenia, schizoaffective disorder, delusional disorder, and schizotypal personality disorder.
45
**Schizophrenia Spectrum Disorders** Core Symptoms of Schizophrenia
1. Delusions: Fixed, false beliefs. 2. Hallucinations: Sensory experiences without stimuli, usually auditory. 3. Disorganized Thinking: Often evidenced through incoherent speech. 4. Abnormal Motor Behavior: Ranges from agitation to catatonia. 5. Negative Symptoms: Reduced emotional expression, motivation, or social engagement.
46
**Schizophrenia Spectrum Disorders** Negative Symptoms
1. Avolition: Lack of motivation. 2. Alogia: Reduced speech. 3. Anhedonia: Inability to feel pleasure. 4. Asociality: Lack of interest in social relationships.
47
**Schizophrenia Spectrum Disorders** Schizophreniform Disorder
Symptoms similar to schizophrenia but lasting 1-6 months, with no requirement for impaired social or occupational functioning.
48
**Schizophrenia Spectrum Disorders** Schizoaffective Disorder
Features of schizophrenia co-occurring with major mood episodes (depressive or manic) for a significant portion of the illness duration.
49
**Schizophrenia Spectrum Disorders** Delusional Disorder
Persistent delusions lasting 1+ months without other schizophrenia spectrum symptoms.
50
**Schizophrenia Spectrum Disorders** Risk Factors for Schizophrenia Spectrum Disorders
1. Genetic Factors: Family history increases risk. 2. Prenatal Complications: Malnutrition, infections, or hypoxia. 3. Early Developmental Issues: Delays in motor skills or language. 4. Environmental Stressors: Urban upbringing, trauma, or cannabis use.
51
**Schizophrenia Spectrum Disorders** Prevalence and Incidence
Schizophrenia affects about 1% of the global population, with onset typically in late adolescence or early adulthood.
52
**Schizophrenia Spectrum Disorders** Neurodevelopmental Hypothesis
Schizophrenia results from disruptions in brain development, influenced by genetic and environmental factors, evident before the illness onset.
53
**Schizophrenia Spectrum Disorders** Differential Diagnosis
Distinguishing schizophrenia spectrum disorders from conditions like mood disorders with psychotic features, substance-induced psychosis, and personality disorders.
54
**Schizophrenia Spectrum Disorders** Treatment Approaches
- Medication: Antipsychotics for symptom control. - Psychotherapy: Cognitive-behavioral therapy (CBT). - Rehabilitation: Social skills training and vocational support.
55
**Schizophrenia Spectrum Disorders** Prognosis
Variable outcomes with a spectrum of recovery, from full remission to chronic disability; better prognosis associated with early intervention and supportive environments.
56
**Schizophrenia Spectrum Disorders** Early Intervention Benefits
Treatment during prodromal or early stages improves long-term outcomes, reducing relapse rates and functional impairment.
57
**Schizophrenia Spectrum Disorders** Comorbidities
Common comorbidities include substance use disorders, depression, anxiety, and cardiovascular diseases.
58
**Lessons from the Wings of Drosophila** Timing of Organ Teratogens in Development
The effects of organ teratogens during fetal development depend heavily on timing. For example, the drug thalidomide acts as a teratogen during one specific week of the first trimester, leading to specific and recognizable effects. Similar mechanisms are observed in *Drosophila melanogaster*, where heat shock during specific developmental windows affects the growth of body parts such as wings and legs.
59
**Lessons from the Wings of Drosophila** Developmental Windows in *Drosophila*
Each part of the *Drosophila* body has a unique narrow developmental window. For instance, heat shock during 37-41 hours of the pupal stage can result in wing deformities, while heat shock during 40-44 hours can impair head development.
60
**Lessons from the Wings of Drosophila** Gene Expression and Teratogens
During critical periods of rapid gene expression in *Drosophila*, teratogens like heat shock can pause development. When the stressor subsides, genes resume expression, but developmental errors remain uncorrected, resulting in deformities.
61
**Lessons from the Wings of Drosophila** Heat Shock as a Model Teratogen
In *Drosophila melanogaster*, heat shock is used as a model teratogen. It highlights how environmental stress during key developmental windows impacts gene expression and morphology, providing insights into the timing and mechanisms of teratogenesis.
62
**Lessons from the Wings of Drosophila** Insights from Drosophila Models
Studies on Drosophila help understand how early developmental disruptions can lead to disorders like schizophrenia.
63
**Lessons from the Wings of Drosophila** Schizophrenia and Developmental Disruption
Schizophrenia may result from environmental disruptions during critical developmental windows.
64
**Lessons from the Wings of Drosophila** Teratogens and Schizophrenia
Environmental factors, such as infections or toxins, during prenatal development could increase schizophrenia risk.
65
**Lessons from the Wings of Drosophila** Heat Shock Analogy in Schizophrenia
The effects of heat shock in *Drosophila* are used as a model to study environmental impacts on brain development in schizophrenia.
66
**Lessons from the Wings of Drosophila** Gene Expression and Schizophrenia
Interruption of gene expression during fetal development may lead to errors associated with schizophrenia.
67
**Lessons from the Wings of Drosophila** Critical Periods and Mental Health
Schizophrenia may arise if disruptions occur during critical periods of brain development.
68
**Lessons from the Wings of Drosophila** Environmental Stress and Schizophrenia
Prenatal stressors, such as maternal infection, can influence neural development and increase schizophrenia risk.
69
**Lessons from the Wings of Drosophila** Insights from *Drosophila* Models
Studies on *Drosophila* help understand how early developmental disruptions can lead to disorders like schizophrenia.
70
**Lessons from the Wings of Drosophila** Developmental Errors in the Brain
Schizophrenia may be linked to uncorrected developmental errors during prenatal brain growth.
71
**Lessons from the Wings of Drosophila** Teratogenic Mechanisms and Psychiatry
Teratogens illustrate how environmental factors disrupt normal development, offering insights into psychiatric conditions like schizophrenia.
72
**Lessons from the Wings of Drosophila** Timing of Neural Development
The brain’s sensitivity to disruptions during specific developmental phases parallels findings in schizophrenia research.
73
**Epidemiology and Natural History of Schizophrenia** Epidemiology in Schizophrenia
The study of the frequency, determinants, incidence, prevalence, and course of schizophrenia in populations.
74
**Epidemiology and Natural History of Schizophrenia** Lifetime Prevalence Rate of Schizophrenia
Approximately 0.7%.
75
**Epidemiology and Natural History of Schizophrenia** Strongly Confirmed Risk Factors for Schizophrenia
Family history of schizophrenia and lower social class.
76
**Epidemiology and Natural History of Schizophrenia** Insidious Onset
A gradual development of symptoms in schizophrenia, making the exact onset of the illness difficult to identify.
77
**Epidemiology and Natural History of Schizophrenia** Research Designs for Schizophrenia Identification
General population surveys, two-stage community surveys, and treatment setting samples.
78
**Epidemiology and Natural History of Schizophrenia** Risk in Children of Two Schizophrenic Parents
Approximately 46.3% higher risk of schizophrenia compared to the general population.
79
**Epidemiology and Natural History of Schizophrenia** Heritability Estimate for Schizophrenia
60% to 70%.
80
**Epidemiology and Natural History of Schizophrenia** Social Drift Hypothesis
The hypothesis that individuals with schizophrenia fail to achieve their potential due to the illness, explaining the inverse relationship between social class and schizophrenia.
81
**Epidemiology and Natural History of Schizophrenia** Male-to-Female Ratio in First-Episode Schizophrenia
More males than females diagnosed, especially in populations under 35 years old.
82
**Epidemiology and Natural History of Schizophrenia** Season of Birth and Schizophrenia Risk
A slightly higher risk of schizophrenia is associated with being born in winter.
83
**Epidemiology and Natural History of Schizophrenia** Prenatal Complications and Schizophrenia Risk
Complications such as preeclampsia, low maternal weight, small head circumference, and fetal distress increase the risk of schizophrenia.
84
**Epidemiology and Natural History of Schizophrenia** Cannabis Consumption and Schizophrenia Risk
Heavy cannabis use is linked to a higher risk of developing schizophrenia, though causation remains uncertain.
85
**Epidemiology and Natural History of Schizophrenia** Predictor of Relapse in Schizophrenia
Noncompliance with medication after treatment begins is the most consistent predictor of relapse.
86
**Epidemiology and Natural History of Schizophrenia** Suffolk County Mental Health Project 24-Month Findings
40.2% of patients with schizophrenia were continuously ill, and only 13.3% achieved complete remission.
87
**Epidemiology and Natural History of Schizophrenia** Key Factors Affecting Schizophrenia Outcomes
Severity of psychosis and insidious onset significantly influence the course of schizophrenia.

PSCI 169C (28 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions